Incidental Histologic Findings During Mohs Micrographic Surgery: A Systematic Review.
메타분석
2/5 보강
TL;DR
To systematically review published cases of incidental histologic findings identified during Mohs micrographic surgery, with attention to their frequency, clinical implications, and management, a systematic review was conducted.
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
680 patients (aged 36-90 years) with incidental findings, of which 26 were findings distinct from the original tumor.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Although many are benign, others may alter prognosis and management. Awareness of these findings and standardized reporting may enhance patient outcomes.
OpenAlex 토픽 ·
Nonmelanoma Skin Cancer Studies
Cancer and Skin Lesions
Cutaneous Melanoma Detection and Management
To systematically review published cases of incidental histologic findings identified during Mohs micrographic surgery, with attention to their frequency, clinical implications, and management, a syst
- 연구 설계 systematic review
APA
Benjamin R. Cooper, Taha Rasul, et al. (2026). Incidental Histologic Findings During Mohs Micrographic Surgery: A Systematic Review.. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 52(4), 310-314. https://doi.org/10.1097/DSS.0000000000004856
MLA
Benjamin R. Cooper, et al.. "Incidental Histologic Findings During Mohs Micrographic Surgery: A Systematic Review.." Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], vol. 52, no. 4, 2026, pp. 310-314.
PMID
40919776 ↗
Abstract 한글 요약
[BACKGROUND] Mohs micrographic surgery (MMS) allows for precise excision of skin cancers with intraoperative histologic margin assessment. Incidental findings-unexpected histopathologic features unrelated to the primary lesion-are occasionally discovered but scantily characterized in the literature.
[OBJECTIVE] To systematically review published cases of incidental histologic findings identified during MMS, with attention to their frequency, clinical implications, and management.
[METHODS] A systematic review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines utilizing PubMed, Wiley Online Library, Google Scholar, and Cochrane Library. Data were extracted regarding patient demographics, tumor type and location, incidental findings, associated implications, treatment, and follow-up.
[RESULTS] Twenty-nine studies were selected for inclusion, describing 680 patients (aged 36-90 years) with incidental findings, of which 26 were findings distinct from the original tumor. One study reported 610 patients with incidental basal and squamous cell carcinoma. Among the remaining 28 studies, the most frequent incidental findings included benign syringomatous hyperplasia, syringomas, Merkel cell carcinoma, and melanoma, with further treatment required for 15.7% of these incidental findings (11/70). In aggregate, 91.3% of reported incidental findings required further treatment (621/680).
[CONCLUSION] Incidental findings during MMS can be clinically important. Although many are benign, others may alter prognosis and management. Awareness of these findings and standardized reporting may enhance patient outcomes.
[OBJECTIVE] To systematically review published cases of incidental histologic findings identified during MMS, with attention to their frequency, clinical implications, and management.
[METHODS] A systematic review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines utilizing PubMed, Wiley Online Library, Google Scholar, and Cochrane Library. Data were extracted regarding patient demographics, tumor type and location, incidental findings, associated implications, treatment, and follow-up.
[RESULTS] Twenty-nine studies were selected for inclusion, describing 680 patients (aged 36-90 years) with incidental findings, of which 26 were findings distinct from the original tumor. One study reported 610 patients with incidental basal and squamous cell carcinoma. Among the remaining 28 studies, the most frequent incidental findings included benign syringomatous hyperplasia, syringomas, Merkel cell carcinoma, and melanoma, with further treatment required for 15.7% of these incidental findings (11/70). In aggregate, 91.3% of reported incidental findings required further treatment (621/680).
[CONCLUSION] Incidental findings during MMS can be clinically important. Although many are benign, others may alter prognosis and management. Awareness of these findings and standardized reporting may enhance patient outcomes.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.